カテゴリー： QYResearch, 世界

世界の内分泌系薬物市場 2019年

【英語タイトル】Global Endocrine System Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X07314）・商品コード：DATA909X07314
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、内分泌系薬物の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、糖尿病治療薬、ヒト成長ホルモン、甲状腺ホルモン障害薬、その他に、用途別には、病院、診療所、医療センター、その他にセグメント区分し、内分泌系薬物の世界市場を分析しました。


・エグゼクティブ・サマリー
・内分泌系薬物の世界市場概要
・内分泌系薬物の製造コスト構成分析
・内分泌系薬物の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・内分泌系薬物の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・内分泌系薬物のセグメント分析（種類別）
（糖尿病治療薬、ヒト成長ホルモン、甲状腺ホルモン障害薬、その他）
・内分泌系薬物のセグメント分析（用途別）
（病院、診療所、医療センター、その他）
・内分泌系薬物の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Novo Nordisk、Sanofi、Merck、Eli Lilly、AstraZeneca、AbbVie、）
・内分泌系薬物の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Endocrine System Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Endocrine System Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endocrine System Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Endocrine System Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Endocrine System Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novo Nordisk
Sanofi
Merck
Eli Lilly
AstraZeneca
AbbVie
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Diabetes Drug
Human Growth Hormones
Thyroid Hormone Disorder Drugs
Others

Segment by Application
Hospital
Clinic
Medical Center
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Endocrine System Drug
1.1 Definition of Endocrine System Drug
1.2 Endocrine System Drug Segment by Type
1.2.1 Global Endocrine System Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Diabetes Drug
1.2.3 Human Growth Hormones
1.2.4 Thyroid Hormone Disorder Drugs
1.2.5 Others
1.3 Endocrine System Drug Segment by Applications
1.3.1 Global Endocrine System Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Others
1.4 Global Endocrine System Drug Overall Market
1.4.1 Global Endocrine System Drug Revenue (2014-2025)
1.4.2 Global Endocrine System Drug Production (2014-2025)
1.4.3 North America Endocrine System Drug Status and Prospect (2014-2025)
1.4.4 Europe Endocrine System Drug Status and Prospect (2014-2025)
1.4.5 China Endocrine System Drug Status and Prospect (2014-2025)
1.4.6 Japan Endocrine System Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Endocrine System Drug Status and Prospect (2014-2025)
1.4.8 India Endocrine System Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Endocrine System Drug
2.3 Manufacturing Process Analysis of Endocrine System Drug
2.4 Industry Chain Structure of Endocrine System Drug

3 Development and Manufacturing Plants Analysis of Endocrine System Drug
3.1 Capacity and Commercial Production Date
3.2 Global Endocrine System Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Endocrine System Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Endocrine System Drug Production and Capacity Analysis
4.2 Endocrine System Drug Revenue Analysis
4.3 Endocrine System Drug Price Analysis
4.4 Market Concentration Degree

5 Endocrine System Drug Regional Market Analysis
5.1 Endocrine System Drug Production by Regions
5.1.1 Global Endocrine System Drug Production by Regions
5.1.2 Global Endocrine System Drug Revenue by Regions
5.2 Endocrine System Drug Consumption by Regions
5.3 North America Endocrine System Drug Market Analysis
5.3.1 North America Endocrine System Drug Production
5.3.2 North America Endocrine System Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Endocrine System Drug Import and Export
5.4 Europe Endocrine System Drug Market Analysis
5.4.1 Europe Endocrine System Drug Production
5.4.2 Europe Endocrine System Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Endocrine System Drug Import and Export
5.5 China Endocrine System Drug Market Analysis
5.5.1 China Endocrine System Drug Production
5.5.2 China Endocrine System Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Endocrine System Drug Import and Export
5.6 Japan Endocrine System Drug Market Analysis
5.6.1 Japan Endocrine System Drug Production
5.6.2 Japan Endocrine System Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Endocrine System Drug Import and Export
5.7 Southeast Asia Endocrine System Drug Market Analysis
5.7.1 Southeast Asia Endocrine System Drug Production
5.7.2 Southeast Asia Endocrine System Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Endocrine System Drug Import and Export
5.8 India Endocrine System Drug Market Analysis
5.8.1 India Endocrine System Drug Production
5.8.2 India Endocrine System Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Endocrine System Drug Import and Export

6 Endocrine System Drug Segment Market Analysis (by Type)
6.1 Global Endocrine System Drug Production by Type
6.2 Global Endocrine System Drug Revenue by Type
6.3 Endocrine System Drug Price by Type

7 Endocrine System Drug Segment Market Analysis (by Application)
7.1 Global Endocrine System Drug Consumption by Application
7.2 Global Endocrine System Drug Consumption Market Share by Application (2014-2019)

8 Endocrine System Drug Major Manufacturers Analysis
8.1 Novo Nordisk
8.1.1 Novo Nordisk Endocrine System Drug Production Sites and Area Served
8.1.2 Novo Nordisk Product Introduction, Application and Specification
8.1.3 Novo Nordisk Endocrine System Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sanofi
8.2.1 Sanofi Endocrine System Drug Production Sites and Area Served
8.2.2 Sanofi Product Introduction, Application and Specification
8.2.3 Sanofi Endocrine System Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Merck
8.3.1 Merck Endocrine System Drug Production Sites and Area Served
8.3.2 Merck Product Introduction, Application and Specification
8.3.3 Merck Endocrine System Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Eli Lilly
8.4.1 Eli Lilly Endocrine System Drug Production Sites and Area Served
8.4.2 Eli Lilly Product Introduction, Application and Specification
8.4.3 Eli Lilly Endocrine System Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 AstraZeneca
8.5.1 AstraZeneca Endocrine System Drug Production Sites and Area Served
8.5.2 AstraZeneca Product Introduction, Application and Specification
8.5.3 AstraZeneca Endocrine System Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 AbbVie
8.6.1 AbbVie Endocrine System Drug Production Sites and Area Served
8.6.2 AbbVie Product Introduction, Application and Specification
8.6.3 AbbVie Endocrine System Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Endocrine System Drug Market
9.1 Global Endocrine System Drug Market Trend Analysis
9.1.1 Global Endocrine System Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Endocrine System Drug Regional Market Trend
9.2.1 North America Endocrine System Drug Forecast 2019-2025
9.2.2 Europe Endocrine System Drug Forecast 2019-2025
9.2.3 China Endocrine System Drug Forecast 2019-2025
9.2.4 Japan Endocrine System Drug Forecast 2019-2025
9.2.5 Southeast Asia Endocrine System Drug Forecast 2019-2025
9.2.6 India Endocrine System Drug Forecast 2019-2025
9.3 Endocrine System Drug Market Trend (Product Type)
9.4 Endocrine System Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Endocrine System Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Endocrine System Drug
Table Global Endocrine System Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Endocrine System Drug Production Market Share by Types in 2018
Figure Diabetes Drug Product Picture
Figure Human Growth Hormones Product Picture
Figure Thyroid Hormone Disorder Drugs Product Picture
Figure Others Product Picture
Table Global Endocrine System Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Endocrine System Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Medical Center
Figure Others
Figure Global Endocrine System Drug Revenue (Million USD) (2014-2025)
Figure Global Endocrine System Drug Production (K Pcs) (2014-2025)
Figure North America Endocrine System Drug Market Size (Million USD) (2014-2025)
Figure Europe Endocrine System Drug Market Size (Million USD) (2014-2025)
Figure China Endocrine System Drug Market Size (Million USD) (2014-2025)
Figure Japan Endocrine System Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Endocrine System Drug Market Size (Million USD) (2014-2025)
Figure India Endocrine System Drug Market Size (Million USD) (2014-2025)
Table Endocrine System Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Endocrine System Drug in 2018
Figure Manufacturing Process Analysis of Endocrine System Drug
Figure Industry Chain Structure of Endocrine System Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Endocrine System Drug Manufacturing Plants Distribution
Table Endocrine System Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Endocrine System Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Endocrine System Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Endocrine System Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Endocrine System Drug Production Share by Manufacturers in 2018
Table Endocrine System Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Endocrine System Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Endocrine System Drug Revenue Share by Manufacturers in 2018
Table Endocrine System Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Endocrine System Drug Production by Regions 2014-2019 (K Pcs)
Table Global Endocrine System Drug Production Market Share by Regions 2014-2019
Figure Global Endocrine System Drug Production Market Share by Regions in 2018
Table Global Endocrine System Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Endocrine System Drug Revenue Market Share by Regions 2014-2019
Figure Global Endocrine System Drug Revenue Market Share by Regions in 2018
Table Global Endocrine System Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Endocrine System Drug Consumption Market Share by Regions 2014-2019
Figure North America Endocrine System Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Endocrine System Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Endocrine System Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Endocrine System Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Endocrine System Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Endocrine System Drug Production, Consumption Import and Export (K Pcs)
Figure China Endocrine System Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Endocrine System Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Endocrine System Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Endocrine System Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Endocrine System Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Endocrine System Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Endocrine System Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Endocrine System Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Endocrine System Drug Production, Consumption Import and Export (K Pcs)
Figure India Endocrine System Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Endocrine System Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Endocrine System Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Endocrine System Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Endocrine System Drug Market Share by Application (2014-2019)
Table Novo Nordisk Endocrine System Drug Production Sites and Area Served
Table Novo Nordisk Endocrine System Drug Product Introduction, Application and Specification
Table Novo Nordisk Endocrine System Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novo Nordisk Endocrine System Drug Production Growth Rate (2014-2019)
Table Novo Nordisk Endocrine System Drug Production Market Share (2014-2019)
Figure Novo Nordisk Endocrine System Drug Revenue Market Share (2014-2019)
Table Novo Nordisk Endocrine System Drug Main Business and Markets Served
Table Sanofi Endocrine System Drug Production Sites and Area Served
Table Sanofi Endocrine System Drug Product Introduction, Application and Specification
Table Sanofi Endocrine System Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanofi Endocrine System Drug Production Growth Rate (2014-2019)
Table Sanofi Endocrine System Drug Production Market Share (2014-2019)
Figure Sanofi Endocrine System Drug Revenue Market Share (2014-2019)
Table Sanofi Endocrine System Drug Main Business and Markets Served
Table Merck Endocrine System Drug Production Sites and Area Served
Table Merck Endocrine System Drug Product Introduction, Application and Specification
Table Merck Endocrine System Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck Endocrine System Drug Production Growth Rate (2014-2019)
Table Merck Endocrine System Drug Production Market Share (2014-2019)
Figure Merck Endocrine System Drug Revenue Market Share (2014-2019)
Table Merck Endocrine System Drug Main Business and Markets Served
Table Eli Lilly Endocrine System Drug Production Sites and Area Served
Table Eli Lilly Endocrine System Drug Product Introduction, Application and Specification
Table Eli Lilly Endocrine System Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly Endocrine System Drug Production Growth Rate (2014-2019)
Table Eli Lilly Endocrine System Drug Production Market Share (2014-2019)
Figure Eli Lilly Endocrine System Drug Revenue Market Share (2014-2019)
Table Eli Lilly Endocrine System Drug Main Business and Markets Served
Table AstraZeneca Endocrine System Drug Production Sites and Area Served
Table AstraZeneca Endocrine System Drug Product Introduction, Application and Specification
Table AstraZeneca Endocrine System Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca Endocrine System Drug Production Growth Rate (2014-2019)
Table AstraZeneca Endocrine System Drug Production Market Share (2014-2019)
Figure AstraZeneca Endocrine System Drug Revenue Market Share (2014-2019)
Table AstraZeneca Endocrine System Drug Main Business and Markets Served
Table AbbVie Endocrine System Drug Production Sites and Area Served
Table AbbVie Endocrine System Drug Product Introduction, Application and Specification
Table AbbVie Endocrine System Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Endocrine System Drug Production Growth Rate (2014-2019)
Table AbbVie Endocrine System Drug Production Market Share (2014-2019)
Figure AbbVie Endocrine System Drug Revenue Market Share (2014-2019)
Table AbbVie Endocrine System Drug Main Business and Markets Served
Figure Global Endocrine System Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Endocrine System Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Endocrine System Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Endocrine System Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Endocrine System Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Endocrine System Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Endocrine System Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Endocrine System Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Endocrine System Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Endocrine System Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Endocrine System Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Endocrine System Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Endocrine System Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Endocrine System Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Endocrine System Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Endocrine System Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Endocrine System Drug by Application (2019-2025)
Table Endocrine System Drug Distributors List
Table Endocrine System Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Novo Nordisk、Sanofi、Merck、Eli Lilly、AstraZeneca、AbbVie、

★調査レポート[世界の内分泌系薬物市場 2019年] (コード：DATA909X07314)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の内分泌系薬物市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の内分泌検査装置市場 2019年
    DATA909X07315 / QYResearch / 2019年11月15日 / ※本調査レポートは、内分泌検査装置の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、体調診断、病気診断、その他に、用途別には、病院、診療所、その他にセグメント区分し、内分泌検査装置の世界市場を分析しました。 ・エグゼクティブ・サマリー ・内分泌検査装置の世界市場概要 ・内分泌検査装置の製造コスト構成分析 ・内分泌検査装置の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・内分泌検査装置の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・内分泌検査装置のセグメント分析（種類別） （体調診断、病気診断、その他）...The global Endocrine Testing Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Endocrine Testing Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endocrine Testing Devices market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Endocrine Testing Devices in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...
  • 世界のファンコニ貧血薬市場 2019年
    DATA909X07597 / QYResearch / 2019年11月15日 / ※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途別には、病院、診療所、その他にセグメント区分し、ファンコニ貧血薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ファンコニ貧血薬の世界市場概要 ・ファンコニ貧血薬の製造コスト構成分析 ・ファンコニ貧血薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ファンコニ貧血薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ファンコニ貧血薬のセグメント分析（種類別） （エルトロンボパグオラミン、EXG-34217、ファンカレン、その他）...The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fanconi Anemia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Fanconi Anemia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の緑膿菌肺炎治療薬市場 2019年
    DATA909X13859 / QYResearch / 2019年11月20日 / ※本調査レポートは、緑膿菌肺炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アエルシン、EV-035、MEDI-3902、パノバクマブ、その他に、用途別には、病院、クリニック、その他にセグメント区分し、緑膿菌肺炎治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・緑膿菌肺炎治療薬の世界市場概要 ・緑膿菌肺炎治療薬の製造コスト構成分析 ・緑膿菌肺炎治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・緑膿菌肺炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・緑膿菌肺炎治療薬のセグメント分析（種類別） （アエルシン、EV-035、MEDI-3902、パノバクマブ、その他）...The global Pseudomonas Aeruginosa Pneumonia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pseudomonas Aeruginosa Pneumonia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pseudomonas Aeruginosa Pneumonia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pseudomonas Aeruginosa Pneumonia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆